Excited to share our latest preprint on work led by postdoc Robert Lusi (@rflusi.bsky.social)! Introducing ALTER (AGO-Led Targeted Editing of RNA) for non-downregulatory RNA manipulation by repurposing hAGO2, non-immunogenic and capitalizing on evolution. www.biorxiv.org/content/10.6...

Really cool approach to an impactful problem from @greenahn.bsky.social @uwproteindesign.bsky.social!

Attend the 2025 Bringing Chemistry to Medicine Symposium to learn from leading experts in transcription, chromatin regulation, computational biology and chemical biology. Registration is free and available both in-person and virtually.

Incredibly proud of @christineisadora.bsky.social for defending her PhD work today! The first PhD from the Banik lab, and an amazing story on targeted protein relocalization and TRAMs! Her PhD work spans small molecules, neurobiology, cell engineering, and computational method development.

If you want to understand how cells function, you have to work out what proteins interact with — and where https://go.nature.com/4hYLaol

Check it out, powerful new method for optical imaging of the live ECM, from @hhmijanelia.bsky.social Group Leader Kayvon Pedram #proudofalumni #glycotime www.nature.com/articles/s41...

Congratulations to @alesalerno.bsky.social from University of Dundee CeTPD and Christine Ng from @stanford-chemh.bsky.social who have been selected as recipients of our conference travel scholarships to attend the Proximity-based Therapeutics Keystone conference @keystonesymposia.bsky.social!

Amazing to see the LYTAC technology get to this point, catalytic extracellular degraders could open many new therapeutic opportunities or perhaps even become standard of care compared to antagonistic antibodies alone. Congrats to Lycia Tx!